3-[1-(4-Isopropylamino-phenyl)-piperidin-4-yl]-propan-1-ol, 250mg

2-Amino-5-isopropylpyridine, 95.0%, 1g

6-BROMOQUINOLINE-5-CARBONITRILE, 97.0%, 250mg

Methyl 4-methoxy-2-nitrobenzoate, 95.0%, 25g

Bisphenol A diglycidyl ether, 84.0%, 200g

Filtration unit with cellulose nitrate membrane Pore size 0.2 μm, without grid, 500 ml, 1000 ml, 75 mm, 12 Piece(s)

Volumetric flasks class A Clear glass, 2000 ml, 29/32, 1 unit(s), 1 Piece

5-bromo-1-methyl-1H-1,3-benzodiazol-2-amine, 95.0%, 250mg

(1S)-(-)-2,10-Camphorsultam, 98.0%, 10g

1-(2-FLUOROPHENYL)CYCLOBUTANE-1-CARBONITRILE, 95.0%, 5g

4-Benzyloxy-3-fluorophenylboronic acid, 97.0%, 10g

(R)?-5,?5',?6,?6',?7,?7',?8,?8'-Octahydro-?3,?3'-?bis(2,?4,?6-?trimethylphenyl)?-[1,?1'-?binaphthalene]?-?2,?2'-?diol, 97%, 100mg

2-Chloro-4-(2,5-difluoro-4-nitrophenoxy)pyridine, 95.0%, 250mg